Argentina-Alzheimer's disease neuroimaging initiative (Arg-ADNI): evolução do perfil neuropsicológico depois de um ano de seguimento
AUTOR(ES)
Méndez, Patricio Chrem, Calandri, Ismael, Nahas, Federico, Russo, María Julieta, Demey, Ignacio, Martín, María Eugenia, Clarens, María Florencia, Harris, Paula, Tapajoz, Fernanda, Campos, Jorge, Surace, Ezequiel I., Martinetto, Horacio, Ventrice, Fernando, Cohen, Gabriela, Vázquez, Silvia, Romero, Carlos, Guinjoan, Salvador, Allegri, Ricardo F., Sevlever, Gustavo
FONTE
Arq. Neuro-Psiquiatr.
DATA DE PUBLICAÇÃO
2018-04
RESUMO
ABSTRACT The Argentina-Alzheimer's disease neuroimaging initiative (Arg-ADNI) study is a longitudinal prospective cohort of 50 participants at a single institution in Buenos Aires, Argentina. Longitudinal assessments on a neuropsychological test battery were performed on 15 controls, 24 mild cognitive impairment (MCI) patients and 12 Alzheimer's disease (AD) dementia patients. In our study population, there was a high prevalence of positive AD biomarkers in the AD group, 92.3% (12/13); and a low prevalence in the normal controls, 20%; almost half (48%) of the patients diagnosed with MCI had positive amyloid detection. After a one year, the significant differences found at baseline on neuropsychological testing were similar at the follow-up assessment even though the AD group had significantly altered its functional performance (FAQ and CDR). The exception was semantic fluency, which showed greater impairment between the AD group and MCI and normal controls respectively. For these tests, the addition of AD biomarkers as a variable did not significantly alter the variations previously found for the established clinical group's model. Finally, the one-year conversion rate to dementia was 20% in the MCI cohort.
ASSUNTO(S)
enfermedad de alzheimer disfunción cognitiva biomarcadores neuroimagen
Documentos Relacionados
- Molecular Neuroimaging in Alzheimer’s Disease
- Hifema traumático: seguimento de um ano
- Evolução da função renal na fase aguda do infarto do miocárdio como fator prognóstico de eventos na fase intra-hospitalar e em um ano de seguimento
- Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications
- A Argentina depois da conversibilidade: um caso de novo-desenvolvimentismo?